Search for: "Bristol-Myers Squibb Company "
Results 401 - 420
of 465
Sort by Relevance
|
Sort by Date
3 Dec 2008, 2:00 pm
But there are potential pitfalls lurking, including one case involving Bristol-Myers Squibb's blood thinner Plavix and AstraZeneca's heartburn drug Prilosec. [read post]
21 Nov 2008, 3:43 pm
Their production companies are looking at Andy Behrman's tell-all about his days as spokesman for Bristol-Myers Squibb's schizophrenia med, Abilify.Behrman, author of "Electroboy: A Memoir of Mania," calls his latest "Adventures in the Drug Trade: I Was a Big Pharma-Pusher. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
15 Oct 2008, 3:02 pm
Much of the lobbying efforts were aimed at Sheldon Bradshaw, who had succeeded Daniel Troy as FDA chief counsel in April 2005.AAJ obtained emails that list attendees of a meeting between Bradshaw and the Pharmaceutical Research and Manufacturers of America (PhRMA) revealing the FDA chief counsel met with legal representatives from Pfizer, Wyeth, Eli Lilly, Berlex, Organon, Abbott Laboratories, Takeda, Sanofi-Aventis, Serono, AstraZeneca, Cephalon, Millenium, Eisai, Amgen, Astellas, GlaxoSmithKline,… [read post]
6 Oct 2008, 12:46 pm
The $70-per-share bid, which boards of both companies have approved, beat out an offer of $62 a share from Bristol-Myers Squibb, which markets ImClone's cancer drug Erbitux in the United States along with ImClone. [read post]
29 Sep 2008, 8:14 pm
Universities, Not Companies, Drive Biotech Advancement, UCSF Today, May 8, 2007.9. [read post]
19 Sep 2008, 6:00 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
10 Sep 2008, 9:32 pm
Recall That Bristol-Myers Had Said Decline In Sales Was Reason For Its Decision To Stop Selling Tequin (Posted by Tom Lamb at DrugInjuryWatch.com) On September 2, 2008 the FDA issued a Notice entitled "Determination That TEQUIN (Gatifloxacin) Was Withdrawn From Sale for Reasons of Safety or Effectiveness" which provides (and confirms) the real reason that Bristol-Myers Squibb Co. [read post]
10 Sep 2008, 6:00 pm
The issue came up in In re Bristol Myers Squibb Co. [read post]
10 Sep 2008, 1:59 pm
That easily tops the $60-per-share cash bid that Bristol-Myers Squibb made in [...] [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
16 Aug 2008, 2:43 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Belgium - eBay wins ruling against L’Oreal in dispute over liability for counterfeit goods sold in online auctions: (Managing Intellectual Property), (Counterfeit Chic), (IPKat), (Class 46), (Techdirt), (Ars Technica) US CAFC holds that copying free software without complying with license is copyright infringement: Robert Jacobsen v… [read post]
17 Jul 2008, 8:34 pm
In addition to Fed Ex, other companies that, following my shareholder proposals, agreed to amend their bylaws to incorporate pill-limiting provisions are JCPenney, Safeway, CVS Caremark, Disney, and Bristol-Myers Squibb. [read post]
17 Jul 2008, 12:11 am
Bristol-Myers Squibb is starting to send out the $500 million refunds to the state governments it ripped off. [read post]
20 Jun 2008, 8:07 am
: (Spicy IP), Latin America: Merck Serono signs distribution agreement with Bristol-Myers Squibb for portfolio of established pharmaceutical brands in Latin America: (IP tango), US: Biotech industry growth to slow due to funding pressures and competition from biosimilars: (Managing Intellectual Property), US: House Commerce Committee posts responses to its questions on biogenerics; not surprisingly, the views run the gamut: (FDA Law Blog), US: Biosimilar debate heats up at… [read post]
18 Jun 2008, 12:26 pm
Bristol-Myers Squibb [read post]
3 Jun 2008, 3:05 am
[7] Some companies, such as GE hold patents in several different categories – this table looks only at those patents in the particular identified category. [read post]
28 May 2008, 8:56 am
"There's not been a default but there's a complete loss of liquidity.'' In January, Bristol-Myers Squibb booked unrealized pretax losses of $142 million on $811 million of ARS, (It also replaced its treasurer.) [read post]
2 May 2008, 7:00 am
: Lupin v Abbott Labs: (FDA Law Blog), Plavix (Clopidogrel) – US: Apotex sues FDA to recover 180-day exclusivity on generic Plavix: (Orange Book Blog), Plavix (Clopidogrel) – US: Former Bristol-Myers Squibb executive charged over lying about Plavix deal struck with rival Apotex: (Managing Intellectual Property), Risperdal (Resperidone) – US: Apotex files motion to intervene in relisting of Risperdal patent case; Teva quickly files… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
